SPCs: a deep dive into CJEU case law
The CJEU’s many attempts to clarify the law around SPCs has created more questions than answers, as Katie Cambrook and Ben Millson of Bristows explain.
- Lanham Act: brand owners’ current weapon of choice 11-06-2020
- COVID-19: governments look to shield companies from IP enforcement 23-04-2020
- Patent pools: should rights owners give up their IP? 21-04-2020
- COVID-19: patent procurement and licensing 31-03-2020
- UK patent system ‘no obstacle’ for ventilator production 19-03-2020
Latest medical devices news
Fed Circ grants Arthrex remand, rejects Iancu conflict
10-09-2020
The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.
3M wins $200k face mask settlement
17-08-2020
Medit scores win in 3Shape patent battle
06-08-2020
